Tuesday, April 14, 2026
wellness India Expo
Home Tags Lupin

Tag: Lupin

Lupin ranks no. 1 globally in pharma; tops all sectors in...

The company attained a score of 91 out of 100, establishing itself as the leading pharmaceutical company globally

Lupin receives European Commission approval for Biosimilar Ranibizumab

Lupin’s biosimilar ranibizumab will be commercialized by Sandoz across the European Union (excluding Germany)

Lupin founder Desh Bandhu Gupta’s biography launched in Mumbai

The book titled "Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma" has been authored by Manish Sabharwal and Sundeep Khanna

Lupin signs exclusive licensing agreement with Gan & Lee Pharmaceuticals for...

The agreement strengthens Lupin’s diabetes portfolio and accelerates its presence in the obesity segment

Lupin receives positive CHMP opinion for Biosimilar Ranibizumab

Ranibizumab is a recombinant humanized IgG1 monoclonal antibody fragment that binds to and inhibits vascular endothelial growth factor A (VEGF-A)

Lupin Manufacturing Solutions and PolyPeptide announce strategic alliance to scale global...

This collaboration aims to enhance supply chain resilience, improve operational efficiency, and accelerate readiness for the rapidly expanding global peptides market

Lupin Foundation earns CRISIL’s highest VO 1A rating for excellence in...

This distinction is testament to LHWRF’s dedication to excellence, transparency, and impact in the realm of social responsibility

Lupin and Valorum enter into an exclusive licensing agreement for ‘Biosimilar...

The company will be responsible for manufacturing and supply of the product and will receive an upfront license fee and a royalty payment on net sales

Lupin receives approval from U.S. FDA for biosimilar Armlupeg™ (Pegfilgrastim-unne)

The product will be manufactured at Lupin’s Biotech facility in Pune, which was inspected by the U.S. FDA prior to approval.

Lupin establishes a new global standard in sustainable pharma with an...

This remarkable increase from 17 in 2021 ranks among the fastest for pharmaceutical companies, establishing Lupin as a leader in sustainable growth